Aptorum Group Ltd. (APM)

1.05 -0.02 (-1.87%) USD  |  NASDAQ  |  Jan 14, 16:00
1.05 0.00 (0.00%) After-Hours: 17:36
More

Aptorum Group Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for APM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade
Tiziana Life Sciences Ltd. --
Mereo BioPharma Group Plc Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade